Kampanjeplan J. B. Chemicals & Pharmaceuticals Limited
Om selskapet J. B. Chemicals & Pharmaceuticals Limited
JB Chemicals & Pharmaceuticals Limited производит и продает различные фармацевтические составы, растительные лекарственные средства и активные фармацевтические ингредиенты в Индии и за рубежом. Его основные продукты включают цилнидипин, ранитидин и метронидазол. Компания также предоставляет услуги по контрактному производству таблеток, пастилок, инъекций, гелей, кремов, мазей, жидких травяных сиропов и капсул; и мягкоцентрированные, порошковые, лекарственные и травяные пастилки, а также различные фармацевтические лекарственные формы. flere detaljer| ISIN | INE572A01036 |
|---|---|
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Валюта | inr |
| Валюта отчета | inr |
| Див.доход ао | 0.6991 |
| Дивиденд ао | 15.25 |
| Сайт | https://www.jbpharma.com |
| Цена ао | 1708.75 |
| Prisendring per dag: | -6.15% (1708.75) |
|---|---|
| Prisendring per uke: | -1.25% (1624) |
| Prisendring per måned: | +1.66% (1577.5) |
| Prisendring over 3 måneder: | -11.54% (1812.8) |
| Prisendring over seks måneder: | -13.41% (1851.95) |
| Prisendring per år: | -2.81% (1650) |
| Prisendring over 3 år: | +2.29% (1567.76) |
| Prisendring over 5 år: | +199.75% (535) |
| Prisendring siden begynnelsen av året: | -12.53% (1833.45) |
|
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
|||||||||||||||||||||||||||||||||||||
| ETF | Dele, % | Lønnsomhet for året, % | Utbytte, % |
|---|---|---|---|
| iShares MSCI India Small-Cap ETF | 0.37698 | 0.4625 | 0.96163 |
| iShares MSCI Emerging Markets Small-Cap ETF | 0.12649 | 7.67 | 2.7853 |
WisdomTree India Earnings Fund
|
0.08254 | 5.23 | 1.65591 |
| WisdomTree Emerging Markets SmallCap Dividend Fund | 0.05238 | 1.35 | 5.00999 |
Vanguard FTSE All-World ex-US Small-Cap ETF
|
0.05 | 9.39 | 3.09932 |
| Dimensional Emerging Markets Core Equity 2 ETF | 0.02602 | 15.96 | 3.34087 |
| SPDR Portfolio MSCI Global Stock Market ETF | 0.02286 | 17.99 | 2.19607 |
| WisdomTree Global ex-U.S. Quality Dividend Growth Fund | 0.01276 | 9.11 | 2.73928 |
| Vanguard ESG International Stock ETF | 0.01 | 6.39 | 3.07501 |
| SPDR Portfolio Emerging Markets ETF | 0.0098 | 11.59 | 3.1879 |
| Dimensional World ex U.S. Core Equity 2 ETF | 0.00964 | 13.06 | 3.62488 |
| FlexShares Morningstar Emerging Markets Factor Tilt Index Fund | 0.00942 | 12.46 | 3.59676 |
iShares Core MSCI Total International Stock ETF
|
0.00701 | 6.4 | 3.25258 |
| Avantis Emerging Markets Equity ETF | 0.00679 | 8.77 | 3.60513 |
| 0.06 | 8.99 | 3.01 |
| Veileder | Stillingstittel | Betaling | Fødselsår |
|---|---|---|---|
| Mr. Nikhil Ashokkumar Chopra | CEO & Whole-Time Director | 65.45M | 1973 (52 år) |
| Mr. Kunal Khanna | President of Operations | N/A | 1980 (45 år) |
| Mr. Sridhar Bharadwaj | Vice President of HR & Administration | N/A | 1967 (58 år) |
| Mr. Pradeep Kumar Singh | President of Global Business | N/A | 1964 (61 år) |
| Mr. Himanshu Ranvah | Vice President of Legal | N/A | 1985 (40 år) |
| Mr. Parmeshwar B. Bang | Executive Vice President of Operations of Daman | N/A | 1968 (57 år) |
| Suresh Amin | Assistant Vice President ? Human Resource | ||
| Mr. Narayan Saraf | Chief Financial Officer | 1980 (45 år) | |
| Mr. Bhagwat Singh Deora | Vice President of Finance & Accounts | 1982 (43 år) | |
| Mr. Suresh Bhise | Vice President of Information & Technology | 1966 (59 år) |
Adresse: India, Mumbai, Cnergy IT Park - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.jbpharma.com
Nettsted: https://www.jbpharma.com
